You are here: Industry Insights > Tsinghua University

News List

Tsinghua and partners to develop neutralising antibodies against COVID-19 pharmaceutical-business-review
April 03, 2020
Tsinghua University has joined forces with 3rd People’s Hospital of Shenzhen and Brii Biosciences (Brii Bio) to develop neutralising antibodies against COVID-19 (novel coronavirus).
Tsinghua University Amgen Scholars Program Officially Launched prnasia
July 05, 2019
The Amgen Scholars Program (ASP) at Tsinghua University, funded by the Amgen Foundation, held its opening ceremony at Tsinghua campus.
BMS and Tsinghua University enter clinical research collaboration pharmaceutical-technology
July 27, 2018
Bristol-Myers Squibb (BMS) has signed a clinical research alliance with Chinese Tsinghua University to facilitate the discovery of drug candidates with new autoimmune disease and cancer targets.
Bristol-Myers Squibb, Tsinghua University pen drug discovery pact fiercebiotech
July 26, 2018
Bristol-Myers Squibb has teamed up with China’s Tsinghua University to discover drugs that hit novel cancer and autoimmune disease targets. The agreement tasks Tsinghua with discovering therapeutics that Bristol-Myers can then choose to license.
BMS collaborates with Tsinghua University for drug development biospectrumasia
July 25, 2018
The collaboration is an expansion of an existing relationship between Bristol-Myers Squibb and Tsinghua University that began in 2012.